Stay updated on MIW815 +/- Ipilimumab in Solid Tumors Clinical Trial

Sign up to get notified when there's something new on the MIW815 +/- Ipilimumab in Solid Tumors Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the MIW815 +/- Ipilimumab in Solid Tumors Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    The footer revision label changed from v3.7.2 to v3.8.0, while the page continues to show a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-11-02T15:51:21.000Z thumbnail image
  2. Check
    10 days ago
    Change Detected
    Summary
    An NIH banner announces a transition from using “Artificial Intelligence” to “Super Intelligence” terminology across NIH content, with updates and FAQs.
    Difference
    1%
    Check dated 2026-10-26T14:36:23.000Z thumbnail image
  3. Check
    17 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov footer revision changed from v3.7.1 to v3.7.2.
    Difference
    0.2%
    Check dated 2026-10-19T14:19:50.000Z thumbnail image
  4. Check
    24 days ago
    Change Detected
    Summary
    The footer revision changes from v3.7.0 to v3.7.1; the page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-12T14:28:36.000Z thumbnail image
  5. Check
    45 days ago
    Change Detected
    Summary
    The page now shows a 403 Forbidden error with the standard header/footer, indicating restricted access to the study record, effectively replacing the study content with an access-denied message.
    Difference
    17%
    Check dated 2026-09-21T22:17:34.000Z thumbnail image
  6. Check
    66 days ago
    Change Detected
    Summary
    The page now displays revision v3.6.6, replacing the previous v3.6.5, indicating a minor version update to the documentation or system.
    Difference
    0.1%
    Check dated 2026-08-31T16:13:45.000Z thumbnail image

Stay in the know with updates to MIW815 +/- Ipilimumab in Solid Tumors Clinical Trial

Enter your email address, and we'll notify you when there's something new on the MIW815 +/- Ipilimumab in Solid Tumors Clinical Trial page.